1 Market Overview
1.1 Orally Disintegrating Tablets Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orally Disintegrating Tablets Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Orally Disintegrating Tablets Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Global Orally Disintegrating Tablets Market Size & Forecast
1.4.1 Global Orally Disintegrating Tablets Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Orally Disintegrating Tablets Sales in Volume (2017-2028)
1.4.3 Global Orally Disintegrating Tablets Price (2017-2028)
1.5 Global Orally Disintegrating Tablets Production Capacity Analysis
1.5.1 Global Orally Disintegrating Tablets Total Production Capacity (2017-2028)
1.5.2 Global Orally Disintegrating Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Orally Disintegrating Tablets Market Drivers
1.6.2 Orally Disintegrating Tablets Market Restraints
1.6.3 Orally Disintegrating Tablets Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Orally Disintegrating Tablets Product and Services
2.1.4 Teva Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Orally Disintegrating Tablets Product and Services
2.2.4 Merck Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Orally Disintegrating Tablets Product and Services
2.3.4 Mylan Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Orally Disintegrating Tablets Product and Services
2.4.4 Pfizer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business
2.5.3 Johnson and Johnson Orally Disintegrating Tablets Product and Services
2.5.4 Johnson and Johnson Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Orally Disintegrating Tablets Product and Services
2.6.4 GSK Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Otsuka
2.7.1 Otsuka Details
2.7.2 Otsuka Major Business
2.7.3 Otsuka Orally Disintegrating Tablets Product and Services
2.7.4 Otsuka Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Orally Disintegrating Tablets Product and Services
2.8.4 Eli Lilly and Company Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Orally Disintegrating Tablets Product and Services
2.9.4 AstraZeneca Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablets Product and Services
2.10.4 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Conquer
2.11.1 Conquer Details
2.11.2 Conquer Major Business
2.11.3 Conquer Orally Disintegrating Tablets Product and Services
2.11.4 Conquer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Orally Disintegrating Tablets Breakdown Data by Manufacturer
3.1 Global Orally Disintegrating Tablets Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Orally Disintegrating Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Orally Disintegrating Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Orally Disintegrating Tablets Manufacturer Market Share in 2021
3.4.2 Top 6 Orally Disintegrating Tablets Manufacturer Market Share in 2021
3.5 Global Orally Disintegrating Tablets Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Orally Disintegrating Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Orally Disintegrating Tablets Market Size by Region
4.1.1 Global Orally Disintegrating Tablets Sales in Volume by Region (2017-2028)
4.1.2 Global Orally Disintegrating Tablets Revenue by Region (2017-2028)
4.2 North America Orally Disintegrating Tablets Revenue (2017-2028)
4.3 Europe Orally Disintegrating Tablets Revenue (2017-2028)
4.4 Asia-Pacific Orally Disintegrating Tablets Revenue (2017-2028)
4.5 South America Orally Disintegrating Tablets Revenue (2017-2028)
4.6 Middle East and Africa Orally Disintegrating Tablets Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Orally Disintegrating Tablets Sales in Volume by Type (2017-2028)
5.2 Global Orally Disintegrating Tablets Revenue by Type (2017-2028)
5.3 Global Orally Disintegrating Tablets Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Orally Disintegrating Tablets Sales in Volume by Application (2017-2028)
6.2 Global Orally Disintegrating Tablets Revenue by Application (2017-2028)
6.3 Global Orally Disintegrating Tablets Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Orally Disintegrating Tablets Sales by Type (2017-2028)
7.2 North America Orally Disintegrating Tablets Sales by Application (2017-2028)
7.3 North America Orally Disintegrating Tablets Market Size by Country
7.3.1 North America Orally Disintegrating Tablets Sales in Volume by Country (2017-2028)
7.3.2 North America Orally Disintegrating Tablets Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Orally Disintegrating Tablets Sales by Type (2017-2028)
8.2 Europe Orally Disintegrating Tablets Sales by Application (2017-2028)
8.3 Europe Orally Disintegrating Tablets Market Size by Country
8.3.1 Europe Orally Disintegrating Tablets Sales in Volume by Country (2017-2028)
8.3.2 Europe Orally Disintegrating Tablets Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Orally Disintegrating Tablets Sales by Type (2017-2028)
9.2 Asia-Pacific Orally Disintegrating Tablets Sales by Application (2017-2028)
9.3 Asia-Pacific Orally Disintegrating Tablets Market Size by Region
9.3.1 Asia-Pacific Orally Disintegrating Tablets Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Orally Disintegrating Tablets Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Orally Disintegrating Tablets Sales by Type (2017-2028)
10.2 South America Orally Disintegrating Tablets Sales by Application (2017-2028)
10.3 South America Orally Disintegrating Tablets Market Size by Country
10.3.1 South America Orally Disintegrating Tablets Sales in Volume by Country (2017-2028)
10.3.2 South America Orally Disintegrating Tablets Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Orally Disintegrating Tablets Sales by Type (2017-2028)
11.2 Middle East & Africa Orally Disintegrating Tablets Sales by Application (2017-2028)
11.3 Middle East & Africa Orally Disintegrating Tablets Market Size by Country
11.3.1 Middle East & Africa Orally Disintegrating Tablets Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Orally Disintegrating Tablets Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Orally Disintegrating Tablets and Key Manufacturers
12.2 Manufacturing Costs Percentage of Orally Disintegrating Tablets
12.3 Orally Disintegrating Tablets Production Process
12.4 Orally Disintegrating Tablets Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Orally Disintegrating Tablets Typical Distributors
13.3 Orally Disintegrating Tablets Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の口腔内崩壊錠市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Orally Disintegrating Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3876 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：100 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 口腔内崩壊錠市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の口腔内崩壊錠の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 口腔内崩壊錠市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・抗精神病薬、抗てんかん薬、その他 用途別セグメントは次のように区分されます。 ・中枢神経系疾患、消化器疾患、CVS疾患、その他 世界の口腔内崩壊錠市場の主要な市場プレーヤーは以下のとおりです。 ・Teva、Merck、Mylan、Pfizer、Johnson and Johnson、GSK、Otsuka、Eli Lilly and Company、AstraZeneca、Bristol-Myers Squibb、Conquer 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、口腔内崩壊錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な口腔内崩壊錠メーカーの企業概要、2019年～2022年までの口腔内崩壊錠の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な口腔内崩壊錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別口腔内崩壊錠の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの口腔内崩壊錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での口腔内崩壊錠市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および口腔内崩壊錠の産業チェーンを掲載しています。 ・第13、14、15章では、口腔内崩壊錠の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 口腔内崩壊錠の概要 - 種類別分析（2017年vs2021年vs2028年）：抗精神病薬、抗てんかん薬、その他 - 用途別分析（2017年vs2021年vs2028年）：中枢神経系疾患、消化器疾患、CVS疾患、その他 - 世界の口腔内崩壊錠市場規模・予測 - 世界の口腔内崩壊錠生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Teva、Merck、Mylan、Pfizer、Johnson and Johnson、GSK、Otsuka、Eli Lilly and Company、AstraZeneca、Bristol-Myers Squibb、Conquer ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：抗精神病薬、抗てんかん薬、その他 ・用途別分析2017年-2028年：中枢神経系疾患、消化器疾患、CVS疾患、その他 ・口腔内崩壊錠の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・口腔内崩壊錠のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・口腔内崩壊錠のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・口腔内崩壊錠の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・口腔内崩壊錠の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Orally Disintegrating Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Orally Disintegrating Tablets market size is estimated to be worth US$ 14290 million in 2021 and is forecast to a readjusted size of USD 29630 million by 2028 with a CAGR of 11.0% during review period. CNS Diseases accounting for % of the Orally Disintegrating Tablets global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-Psychotics Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Orally Disintegrating Tablets include Teva, Merck, Mylan, Pfizer, and Johnson and Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Orally Disintegrating Tablets market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Market segment by Application can be divided into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
The key market players for global Orally Disintegrating Tablets market are listed below:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablets, with price, sales, revenue and global market share of Orally Disintegrating Tablets from 2019 to 2022.
Chapter 3, the Orally Disintegrating Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Orally Disintegrating Tablets market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablets.
Chapter 13, 14, and 15, to describe Orally Disintegrating Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の口腔内崩壊錠市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3876)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の口腔内崩壊錠市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
